Variant #0000011510 (NC_000012.11:-, MYL2(NM_000432.3):c.64G>A)
| Chromosome |
12 |
| Allele |
Unknown |
| Affects function (as reported) |
Affects function |
| Affects function (by curator) |
Not classified |
| Type |
BL21 expression host cells; Sf9 cells |
| DNA change (genomic) (Relative to hg19 / GRCh37) |
- |
| Reference |
GenBank |
| DB-ID |
MYL2_00006 See all 3 reported entries |
| Frequency |
- |
| Variant remarks |
The KCa value for E22K was decreased be ~17-fold compared with the wild-type light chain. Was Associated with a particular subtype of cardiac hypertrophy defined by mid-left ventricular obstruction. The phosphorylation of the FHC mutants affected their Ca2+ binding properties and prevented the E22K mutant from becoming phosphorylated. The nonphosphorylated E22K migrates slower than the nonphosphorylated wild-type HCRLC. E22K mutation results in an increase in the alpha-helical content of HCRLC from 18% to 24%. |
| ClassClinical |
- |
| Average frequency (gnomAD v.2.1.1) |
Retrieve |
| Owner |
Qi Ming |
| Database submission license |
No license selected |
| Created by |
Qi Ming |

Variant on transcripts
|
|